EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Track record

Tools

  • Compare
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›ABSI

ABSI

Absci Corp

Next earnings Aug 10, 2026 · consensus $-0.21 EPS, $1.26M rev

Last earnings -3.4% on 2026-05-07

Avoid
$10.89
▲ +6.66%
$10.89▲ +290.32%
over 1Y
L $2.30EODHDH $10.89
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+6.7%
1W+6.7%
1M+111.0%
3M+291.7%
YTD+201.7%
1Y+290.3%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Watch
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 16 analysts
Buy

Conservative balance sheet (liabilities/equity 0.14x); but revenue fell -38.2% YoY.

Absci Corp shows $2.80M in FY2025 revenue (-38.2% YoY), a -4113.7% net margin, and -60.8% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$4.01M$4.53M$5.72M$4.53M$2.80M
Gross profit—————
Operating income-$75.2M-$107M-$116M-$109M-$120M
Net income-$101M-$105M-$111M-$103M-$115M
Diluted EPS-$2.08-$1.15-$1.20-$0.94-$0.84
Net margin-2518.3%-2316.3%-1933.6%-2274.1%-4113.7%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$1.65B
EV / EBITDA—
EV / Sales589.4
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-6.9%
FCF yield-5.6%

Quality & risk

ROIC (est.)-49.1%
Free cash flow-$94.0M
Total debt$3.99M
Net cash$16.0M
Altman Z-Score32.08 safe
Piotroski F-Score3/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+20.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Material agreement2026-06-24
  2. 8-K Other event2026-06-24
  3. 8-K Shareholder vote2026-06-05
  4. 8-K Earnings results2026-05-07
  5. 10-Q Quarterly report2026-05-07
  6. DEF 14A Proxy statement2026-04-22
  7. 8-K Earnings results2026-03-24
  8. 10-K Annual report2026-03-24
  9. 8-K Officer / director change2026-03-06

Recent filings

all on EDGAR ↗
4Period ending 2026-06-242026-06-26open ↗8-KPeriod ending 2026-06-242026-06-24open ↗424B5Filing2026-06-24open ↗8-KPeriod ending 2026-06-242026-06-24open ↗4/APeriod ending 2026-06-042026-06-15open ↗4Period ending 2026-06-042026-06-11open ↗4Period ending 2026-06-042026-06-08open ↗4Period ending 2026-06-042026-06-08open ↗4Period ending 2026-06-042026-06-08open ↗4Period ending 2026-06-042026-06-08open ↗4Period ending 2026-06-042026-06-08open ↗8-KPeriod ending 2026-06-042026-06-05open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueF
GrowthF
ProfitabilityF
Financial healthB-
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$2.80M
-38.2% YoY
Net margin
-4113.7%
ROE
-60.8%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$2.80M-38.2%
Net income-$115M-11.7%
Operating income-$120M-10.5%
Diluted EPS-$0.84+10.6%
Cash & equivalents$20.0M-51.4%
Total assets$216M+1.3%
Total liabilities$26.8M-22.1%
Stockholders' equity$189M+5.8%
Op.: -4297.0%L/E: 0.14x

Frequently asked

Is Absci Corp (ABSI) a buy?
ABSI currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.14x); but revenue fell -38.2% YoY.
What is Absci Corp's quality score?
ABSI scores 31/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001672688, latest 10-Q filed 2026-05-07) · EODHD · as of 6/23/2026, 1:13:11 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-24
McClain Sean
Chief Executive Officer
Tax59.9K @ $10.08$603K
2026-06-04
MCGINNIS KAREN K
Director
Award10.1K
2026-06-04
Szela Mary T
Director
Award10.1K
2026-06-04
Pangalos Menelas N
Director
Award10.1K
2026-06-04
VAN HOUTEN FRANS
Director
Award10.1K
2026-06-04
Rabinovitsj Daniel A
Director
Award10.1K
2026-06-04
Sirosh Joseph
Director
Award10.1K
2026-05-31
Jonasson Zachariah
CFO / CBO
Tax8.32K @ $6.75$56.2K

Earnings history

beat/miss · move
2026-05-07Beat +11.3% est▼ -3.36%8-K ↗
2026-03-24Miss -0.9% est▲ +2.73%8-K ↗
2025-11-12Beat +7.4% est▼ -1.45%8-K ↗
2025-08-12Miss -11.0% est▲ +4.21%8-K ↗
2025-05-13—▲ +1.02%8-K ↗
2025-03-18—▼ -4.05%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Absci (ABSI) Is Up 37.8% After ABS-201 Data And Equity Raise - Has The Bull Case Changed?Bullish
finance.yahoo.com· 2026-06-26
ABSI Soars 36% on Positive Interim Update From Phase I Hair Loss StudyBullish
finance.yahoo.com· 2026-06-25
ABSCI CORP (ABSI) Soars 36.0%: Is Further Upside Left in the Stock?Bullish
finance.yahoo.com· 2026-06-25
6 Biotech Stocks That Delivered Stunning Gains: INBX +700%, PVLA +500%, MBX +300%, ABSI +200% & MoreBullish
nasdaq.com· 2026-06-24
Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumbleBullish
finance.yahoo.com· 2026-06-24
Absci surges on Eli Lilly, private equity investmentsBullish
seekingalpha.com· 2026-06-24

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score31 vs 67
Revenue growth-38.2% vs 7.1%
Net margin-4113.7% vs 10.5%
Return on equity-60.8% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 14d
Bullish
+0.17
vs typical · 18 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.